Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Dermatology diseases includes common skin rashes to severe skin infections, which occurs due to range of things, such as infections, heat, allergens, system disorders and medications.
The report details the trend, potential and market size of Prescription Dermatological Medications market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Prescription Dermatological Medicationsmarket, defines the market attractiveness level of Prescription Dermatological Medications market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Prescription Dermatological Medications industry, describes the types of Prescription Dermatological Medications market, the applications of major players and the market size, and deeply analyzes the current situation of the global Prescription Dermatological Medications market and the development prospects and opportunities of Prescription Dermatological Medications industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Prescription Dermatological Medications market in Chapter 13.
By Player:
Bristol-Myers Squibb
Barrier Therapeutics
Novartis
Bausch Health
Mylan Pharmaceuticals
Galderma
PharmaDerm
Almirall
Pfizer
By Type:
Oral
Topical
By End-User:
Hospital Pharmacies
Online Pharmacies
Retail Pharmacies
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Prescription Dermatological Medications Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Prescription Dermatological Medications Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Prescription Dermatological Medications Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Prescription Dermatological Medications Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Prescription Dermatological Medications Market Analysis and Outlook to 2022
-
7.1 Global Prescription Dermatological Medications Consumption (2017-2022)
-
7.2 United States Prescription Dermatological Medications Consumption (2017-2022)
-
7.3 Europe Prescription Dermatological Medications Consumption (2017-2022)
-
7.4 China Prescription Dermatological Medications Consumption (2017-2022)
-
7.5 Japan Prescription Dermatological Medications Consumption (2017-2022)
-
7.6 India Prescription Dermatological Medications Consumption (2017-2022)
-
7.7 South Korea Prescription Dermatological Medications Consumption (2017-2022)
8 Region and Country-wise Prescription Dermatological Medications Market Analysis and Outlook to 2028
-
8.1 Global Prescription Dermatological Medications Consumption Forecast (2022-2028)
-
8.2 United States Prescription Dermatological Medications Consumption Forecast (2022-2028)
-
8.3 Europe Prescription Dermatological Medications Consumption Forecast (2022-2028)
-
8.4 China Prescription Dermatological Medications Consumption Forecast (2022-2028)
-
8.5 Japan Prescription Dermatological Medications Consumption Forecast (2022-2028)
-
8.6 India Prescription Dermatological Medications Consumption Forecast (2022-2028)
-
8.7 South Korea Prescription Dermatological Medications Consumption Forecast (2022-2028)
9 Global Prescription Dermatological Medications Market Outlook by Types and Applications to 2022
-
9.1 Global Prescription Dermatological Medications Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Oral Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Topical Consumption and Growth Rate (2017-2022)
-
9.2 Global Prescription Dermatological Medications Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Hospital Pharmacies Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Online Pharmacies Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Retail Pharmacies Consumption and Growth Rate (2017-2022)
10 Global Prescription Dermatological Medications Market Outlook by Types and Applications to 2028
-
10.1 Global Prescription Dermatological Medications Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Oral Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Topical Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Prescription Dermatological Medications Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Hospital Pharmacies Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Online Pharmacies Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Retail Pharmacies Consumption Forecast and Growth Rate (2022-2028)
11 Global Prescription Dermatological Medications Import and Export Analysis (Top 5 Countries)
-
11.1 Global Prescription Dermatological Medications Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Prescription Dermatological Medications Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Prescription Dermatological Medications Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Prescription Dermatological Medications Market Competitive Analysis
-
14.1 Bristol-Myers Squibb
-
14.1.1 Bristol-Myers Squibb Company Details
-
14.1.2 Bristol-Myers Squibb Prescription Dermatological Medications Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Bristol-Myers Squibb Prescription Dermatological Medications Product and Service
-
14.2 Barrier Therapeutics
-
14.2.1 Barrier Therapeutics Company Details
-
14.2.2 Barrier Therapeutics Prescription Dermatological Medications Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Barrier Therapeutics Prescription Dermatological Medications Product and Service
-
14.3 Novartis
-
14.3.1 Novartis Company Details
-
14.3.2 Novartis Prescription Dermatological Medications Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Novartis Prescription Dermatological Medications Product and Service
-
14.4 Bausch Health
-
14.4.1 Bausch Health Company Details
-
14.4.2 Bausch Health Prescription Dermatological Medications Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Bausch Health Prescription Dermatological Medications Product and Service
-
14.5 Mylan Pharmaceuticals
-
14.5.1 Mylan Pharmaceuticals Company Details
-
14.5.2 Mylan Pharmaceuticals Prescription Dermatological Medications Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Mylan Pharmaceuticals Prescription Dermatological Medications Product and Service
-
14.6 Galderma
-
14.6.1 Galderma Company Details
-
14.6.2 Galderma Prescription Dermatological Medications Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 Galderma Prescription Dermatological Medications Product and Service
-
14.7 PharmaDerm
-
14.7.1 PharmaDerm Company Details
-
14.7.2 PharmaDerm Prescription Dermatological Medications Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 PharmaDerm Prescription Dermatological Medications Product and Service
-
14.8 Almirall
-
14.8.1 Almirall Company Details
-
14.8.2 Almirall Prescription Dermatological Medications Sales, Price, Value and Gross Profit (2017-2022)
-
14.8.3 Almirall Prescription Dermatological Medications Product and Service
-
14.9 Pfizer
-
14.9.1 Pfizer Company Details
-
14.9.2 Pfizer Prescription Dermatological Medications Sales, Price, Value and Gross Profit (2017-2022)
-
14.9.3 Pfizer Prescription Dermatological Medications Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Prescription Dermatological Medications
-
Figure Prescription Dermatological Medications Picture
-
Table Global Prescription Dermatological Medications Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Prescription Dermatological Medications Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Prescription Dermatological Medications Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Prescription Dermatological Medications Consumption by Country (2017-2022)
-
Figure United States Prescription Dermatological Medications Consumption and Growth Rate (2017-2022)
-
Table Europe Prescription Dermatological Medications Consumption and Growth Rate (2017-2022)
-
Figure China Prescription Dermatological Medications Consumption and Growth Rate (2017-2022)
-
Figure Japan Prescription Dermatological Medications Consumption and Growth Rate (2017-2022)
-
Figure India Prescription Dermatological Medications Consumption and Growth Rate (2017-2022)
-
Figure South Korea Prescription Dermatological Medications Consumption and Growth Rate (2017-2022)
-
Figure Global Prescription Dermatological Medications Consumption Forecast by Country (2022-2028)
-
Figure United States Prescription Dermatological Medications Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Prescription Dermatological Medications Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Prescription Dermatological Medications Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Prescription Dermatological Medications Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Prescription Dermatological Medications Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Prescription Dermatological Medications Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Oral Consumption and Growth Rate (2017-2022)
-
Figure Global Topical Consumption and Growth Rate (2017-2022)
-
Figure Global Hospital Pharmacies Consumption and Growth Rate (2017-2022)
-
Figure Global Online Pharmacies Consumption and Growth Rate (2017-2022)
-
Figure Global Retail Pharmacies Consumption and Growth Rate (2017-2022)
-
Figure Global Oral Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Topical Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hospital Pharmacies Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Online Pharmacies Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Retail Pharmacies Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Prescription Dermatological Medications Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Prescription Dermatological Medications Export by Region (Top 5 Countries) (2017-2028)
-
Table Bristol-Myers Squibb (Foundation Year, Company Profile and etc.)
-
Table Bristol-Myers Squibb Prescription Dermatological Medications Sales, Price, Value and Gross Profit (2017-2022)
-
Table Bristol-Myers Squibb Prescription Dermatological Medications Product and Service
-
Table Barrier Therapeutics (Foundation Year, Company Profile and etc.)
-
Table Barrier Therapeutics Prescription Dermatological Medications Sales, Price, Value and Gross Profit (2017-2022)
-
Table Barrier Therapeutics Prescription Dermatological Medications Product and Service
-
Table Novartis (Foundation Year, Company Profile and etc.)
-
Table Novartis Prescription Dermatological Medications Sales, Price, Value and Gross Profit (2017-2022)
-
Table Novartis Prescription Dermatological Medications Product and Service
-
Table Bausch Health (Foundation Year, Company Profile and etc.)
-
Table Bausch Health Prescription Dermatological Medications Sales, Price, Value and Gross Profit (2017-2022)
-
Table Bausch Health Prescription Dermatological Medications Product and Service
-
Table Mylan Pharmaceuticals (Foundation Year, Company Profile and etc.)
-
Table Mylan Pharmaceuticals Prescription Dermatological Medications Sales, Price, Value and Gross Profit (2017-2022)
-
Table Mylan Pharmaceuticals Prescription Dermatological Medications Product and Service
-
Table Galderma (Foundation Year, Company Profile and etc.)
-
Table Galderma Prescription Dermatological Medications Sales, Price, Value and Gross Profit (2017-2022)
-
Table Galderma Prescription Dermatological Medications Product and Service
-
Table PharmaDerm (Foundation Year, Company Profile and etc.)
-
Table PharmaDerm Prescription Dermatological Medications Sales, Price, Value and Gross Profit (2017-2022)
-
Table PharmaDerm Prescription Dermatological Medications Product and Service
-
Table Almirall (Foundation Year, Company Profile and etc.)
-
Table Almirall Prescription Dermatological Medications Sales, Price, Value and Gross Profit (2017-2022)
-
Table Almirall Prescription Dermatological Medications Product and Service
-
Table Pfizer (Foundation Year, Company Profile and etc.)
-
Table Pfizer Prescription Dermatological Medications Sales, Price, Value and Gross Profit (2017-2022)
-
Table Pfizer Prescription Dermatological Medications Product and Service
-
